[Evaluation of the therapeutic action of DOPA and phosphaden in experimental dystrophic changes of the retina induced by disorders of the functional state of the sympatho-adrenal system].
D000249:Adenosine Monophosphate / Q000627:therapeutic use*; D000313:Adrenal Medulla / Q000187:drug effects / Q000502:physiology*; D000818:Animals; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D004353:Drug Evaluation, Preclinical; D008268:Macular Degeneration / Q000188:drug therapy* / Q000209:etiology; D011817:Rabbits; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000502:physiology*
D000249:Adenosine Monophosphate; D004295:Dihydroxyphenylalanine
Otsenka lechebnogo deĭstviia DOFA, fosfadena pri éksperimental'nykh distroficheskikh izmeneniiakh setchatoĭ obolochki, vyzvannykh narusheniem funktsional'nogo sostoianiia simpatiko-adrenalovoĭ sistemy.